Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
公司代码PMI
公司名称Picard Medical Inc
上市日期Aug 29, 2025
CEOSchnegelsberg (Patrick N.J)
员工数量75
证券类型Ordinary Share
年结日Aug 29
公司地址1992 E. Silverlake Rd.
城市TUCSON
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编85713
电话15203080796
网址
公司代码PMI
上市日期Aug 29, 2025
CEOSchnegelsberg (Patrick N.J)